Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 May 2024 | Story Anthony Mthembu | Photo SUPPLIED
EMS-Awards-2024
From left to right: Prof Philippe Burger, Dean of the Faculty of Economic and Management Sciences (EMS) at the University of the Free State (UFS), presenting an award to Ntswaki Moshwaisi.

A cohort of esteemed academic and support staff from the Faculty of Economic and Management Sciences (EMS) at the University of the Free State (UFS), received well-deserved accolades at the 2024 annual EMS Awards. Notable among them were Programme Coordinator Ntswaki Moshwaisi and Associate Professor Prof Liezel Massyn from the UFS Business School.

Prof Massyn was lauded in the Teaching and Learning category, while Moshwaisi garnered recognition in the Support Staff category at the awards ceremony held on 18 April 2024, on the UFS Bloemfontein campus.

Reflecting on her achievement, Moshwaisi expressed gratitude, stating, “The award serves as motivation to myself to keep working hard and to innovate methods and approaches towards my work.’’

The significance of the awards

Prof Massyn remarked that the awards serve to spotlight the remarkable contributions of both academics and support staff within the faculty. She considers the award as a testament to her dedication, acknowledged by her esteemed colleagues. Both Prof Massyn and Moshwaisi attribute their success to the support they receive from their peers.

Moreover, they emphasise that these awards transcend mere recognition. It will serve as an impetus to the way forward. Moshwaisi envisages leveraging her award to enhance the quality and efficacy of the programmes under her stewardship. Prof Massyn, echoing this statement, asserts, ’’It will strengthen my belief in the transformative power of teaching and make me work harder to provide quality learning opportunities to students. I am a firm believer in following an evidence-based approach and will continue to research learning and teaching.’’

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept